Francesca Mengoni

Francesca Mengoni

Auto-generated profile, based on publicly available information

Francesca Mengoni

Section of Anatomy and Histology Department of Neurosciences, Biomedicine, and Movement Science School of Medicine University of Verona Verona Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2021 in Epilepsia
Verified
Journal Article
Open access
FMFrancesca Mengoni
Francesca Mengoni
VSValentina Salari
Valentina Salari
IKInna Kosenkova
Inna Kosenkova
GTGrygoriy Tsenov
Grygoriy Tsenov
Massimo DonadelliMassimo Donadelli
Massimo Donadelli
Paolo FabenePaolo Fabene
Paolo Fabene
A bulk of data suggest that the gut microbiota plays a role in a broad range of diseases, including those affecting the central nervous system. Recently, significant differences in the intestinal microbiota of patients with epilepsy, compared to healthy volunteers, have been reported in an observational study. However, an active role of the intestinal microbiota in the pathogenesis of epilepsy, through the so‐called “gut–brain axis,” has yet to be demonstrated. In this study, we evaluated the direct impact of microbiota transplanted from epileptic animals to healthy recipient animals, to clarify whether the microbiota from animals with epilepsy can affect the excitability of the recipients’ brain by lowering seizure thresholds. Our results provide the first evidence that mice who received microbiota from epileptic animals are more prone to develop status epilepticus, compared to recipients of “healthy” microbiota, after a subclinical dose of pilocarpine, indicating a higher susceptibility to seizures. The lower thresholds for seizure activity found in this study support the hypothesis that the microbiota, through the gut–brain axis, is able to affect neuronal excitability in the brain.